Fibrin Glue Market was valued at USD 639.1 Mn in 2024, and total Global Fibrin Glue Market revenue is expected to grow at a CAGR of 7.8% from 2025 to 2032, reaching nearly USD 1165.52 Mn.Fibrin Glue Market Overview
Fibrin glue is biological tissue adhesive derived from plasma proteins, used to promote haemostasis and accelerate wound healing during surgical procedures. The fibrin glue market includes manufacturing, distribution and application across various surgical specialties, with rising adoption by its clinical advantages over traditional sutures and cautery. Key drivers has been the increasing prevalence of complex surgeries like cardiovascular and orthopaedic interventions and the superior outcomes offered by fibrin-based sealants. Demand is fuelled by growing preference for minimally invasive procedures, while supply is influenced by stringent plasma sourcing and purification standards. North America led the market in 2024, owing to advanced healthcare infrastructure and FDA approved innovations, Asia Pacific is rapidly growing by healthcare access expansion and rising surgical volumes. Industry leaders like Johnson & Johnson (Ethicon), Baxter and Takeda drive innovation and global reach through strategic acquisitions. Hospitals remain the dominant end user segment, supported by favourable reimbursement policies that further accelerate adoption across high bleeding procedures. The report covers the Fibrin Glue market dynamics, structure, by analyzing the market segments and projecting the Fibrin Glue Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies and regional presence in the Fibrin Glue Market.To know about the Research Methodology :- Request Free Sample Report
Fibrin Glue Market Dynamics
Increasing Adoption of Haemostats in Surgical Procedures to Boost the Fibrin Glue Market The increasing number of complex surgeries, such as cardiac surgeries, across the globe, owing to the rising prevalence of cardiac diseases in developing countries, will contribute to the rising adoption of haemostats during the forecast period. According to the America Hospital Association survey (2018), an estimated 17.2 million ambulatory hospital visits or inpatient stays required invasive, therapeutic surgery in the United States. Certain advantages associated with application of fibrin Glue such as improved patient outcomes, minimal complications, and reduced chances of mortality are projected to accelerate the fibrin Glue market demand during forecast period. Additionally, superiority of fibrin Glue over limitations of conventional methods such as cautery or sutures may lead to increased adoption of fibrin glue in near future. Furthermore, new product launches and technological advancements in fibrin Glue industry are anticipated to offer lucrative growth opportunities for minimally invasive surgeries, which will eventually boost the growth of the market by 2032. For instance, in November 2018, Baxter introduced New Tisseel Prima Syringe at 2024 American Association of Gynecologic Laparoscopists Meeting. Baxter’s trusted Tisseel fibrin sealant now features the new Prima syringe, which is a next-generation ergonomic syringe that comes fully assembled and is eight times easier to push than the previous Tisseel syringe. Attractive Medical Reimbursement Policies to Increase the Adoption of Fibrin Glue Favourable medical reimbursement policies implemented by government authorities is expected to offer significant opportunities for the growth of this market during the forecast period. Strict implementation of reimbursement policies in developed countries is likely to encourage the utilization of hemostats in high bleeding surgical procedures, which will eventually drive the fibrin glue market revenue till 2032. High Production Costs and Risk of Viral Contamination to Challenge the Fibrin Glue Market A big problem in the fibrin glue market is the high cost to make and clean fibrin adhesives. Fibrin glue comes from human or animal blood, which can carry viruses. This means it needs strict checks and high standards. These things make it hard to sell fibrin glue, especially where people need low-cost options.Fibrin Glue Market Segmentation
Based on Type, the market can be segmented into liquid and patches. In terms of revenue, the liquid segment is estimated to dominate the fibrin glue market owing to enhanced procedural outcomes over other patches. Moreover, qualities of liquid solutions such as fast action and higher rational stability are projected to further drive this segment. One of the major advantages of fibrin sealant patch is that it can achieve haemostasis within 3-4 minutes of application.Based on End User, the market is segmented into hospitals, specialty clinics, and others. The hospitals segment is estimated to dominate the fibrin glue market share throughout the forecast period. Increasing number of CABG (coronary artery bypass grafting) and other cardiovascular surgeries in hospitals are projected to drive the hospitals segment during the forecast period. For instance, according to research conducted by the Agency for Healthcare Research and Quality, the volume of percutaneous transluminal coronary angioplasty procedures increased by an estimated 20.0% in U.S. hospitals. Combined with this is the gradual shift of patient preference from inpatient visits to outpatient visits, which is anticipated to offer significant growth opportunities for the specialty clinics end user segment during 2025-2032. The others segment, which includes ambulatory surgery centres, and other care facilities, is expected to hold lower market share owing to lower demand from advanced healthcare facilities in developing as well as developed countries.
Fibrin Glue Market Regional Insights
North America was the Dominating Region in the Fibrin Glue Market and is Expected to Dominate During Forecast Period In 2024, North America dominated the global Fibrin Glue market, accounting for the largest regional share. The fibrin glue market in the USA grows as more people want better ways to heal wounds and seal surgery cuts. More doctors now use fibrin glue to stop bleeding. This glue is used a lot in heart, bone, and rebuilding surgeries. The FDA checks these products to make sure they work well and are safe. Key trends include more use of fibrin glue that's made from natural sources. Easy surgery methods are getting more advanced, and there's increased study into healing with fibrin glue. The glue is being used more in dental and eye surgeries, adding to its growing market Fibrin Glue Market Competitive Landscape Fibrin glue market is competive and innovation driven, with leading players focusing on product development, global expansion and strategic collaborations. Johnson & Johnson's Ethicon division, holds dominant position with its strong portfolio of surgical sealants and haemostatic agents. Company benefits from vast R&D capabilities and global distribution, making it a trusted brand across hospitals and specialty clinics. Baxter International Inc. is another market leader offering TISSEEL and ARTISS well established fibrin sealants approved in multiple regions. Baxter’s innovation in bio surgery and strong regulatory track record enhance its global footprint, mainly in orthopaedics and cardiovascular surgery segments. Takeda Pharmaceutical Company Ltd has its expertise in plasma derived therapies to supply high quality fibrinogen and thrombin components for sealants. Its global manufacturing facilities and regulatory strength in both Europe and Asia Pacific make it a key player in emerging markets. The market with a focus on safety, minimally invasive procedures and broader surgical applications. Competitive dynamics are further intensified by regional players entering with cost-effective alternatives and by increasing demand for advanced wound management solutions in both developed and developing economies. Fibrin Glue Market TrendsFibrin Glue Market Key Developments • 1st July 2024, Corza Medical (U.S) completed the acquisition of Takeda's TachoSil manufacturing operations in Linz, Austria, giving Corza direct control over production and anticipating improved service levels and global customer support for its fibrin patch portfolio. • In January 2024, Takeda Pharmaceutical Company (Switzerland) completed a strategic merger with BioSeal Technologies, specialist in fibrin sealant and hemostatic technologies by subsidiary. This enhances Takeda’s technical capabilities in surgical bleeding control without changing its corporate structure. • 26th February 2024, Principal Technologies (India) acquired Vivostat, a Danish specialist in autologous fibrin sealant, through a complete equity purchase, strengthening its position in EMEA by integrating Vivostat’s advanced, patient specific wound sealing technology used in over 200,000 surgeries. • 11th January 2023, Grifols (U.S) unveiled positive Phase 3b clinical trial results for Grifols FS, a plasma protein–based fibrin sealant in pediatric patients building on prior adult approvals in the U.S. and Europe and paving the way for expanded use in younger populations. • 15th November 2023, Ethicon (Belgium) part of Johnson & Johnson MedTech, launched ETHIZIA a synthetic hemostatic sealing patch demonstrated to stop bleeding within 30 seconds in 82% of cases, outperforming leading fibrin patches by up to sixfold, following the 2022 acquisition of Netherlands- based GATT Technologies; the product has CE mark approval and is being globally rolled out.
Trends Details Rising Demand for Minimally Invasive Surgeries Surgeons increasingly prefer fibrin glue for its ease of use and reduced tissue trauma during minimally invasive procedures, particularly in orthopaedics and CV. Advancements in Plasma-Derived Biologics Technological innovations in blood component extraction and purification are improving the efficacy, shelf-life, and safety of fibrin sealants. Expanding Use in Emerging Healthcare Markets Growth in surgical procedures and better access to healthcare in Asia Pacific, Latin America, and the Middle East is fueling demand for fibrin glue products. Fibrin Glue Market Scope : Inquire before buying
Fibrin Glue Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 639.1 Mn. Forecast Period 2025 to 2032 CAGR: 7.8% Market Size in 2032: USD 1165.52 Mn. Segments Covered: by Type Liquid Patches by Application Orthopaedic Surgery Cardiovascular Surgery General Surgery Transplant Surgery Others by End User Hospitals Speciality Clinics Others Fibrin Glue Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Thailand, Bangladesh, Philippines and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Fibrin Glue Market Key Players
North America 1. Johnson & Johnson (U.S) 2. Baxter International Inc. (U.S) 3. Pfizer Inc. (U.S) 4. Grifols S.A. (U.S) 5. Haemonetics Corporation (U.S) 6. Integra LifeSciences (U.S) 7. CryoLife, Inc. (U.S) 8. Becton, Dickinson and Company (U.S) Europe 9. Takeda Pharmaceutical (Switzerland) 10. B. Braun Melsungen AG (Germany) 11. Octapharma AG (Switzerland) 12. Biotest AG (Germany) 13. Kedrion Biopharma (Italy) 14. CSL Behring (Germany) 15. Ethicon (Belgium) 16. Vivostat A/S (Denmark) Asia Pacific 17. Shanghai RAAS Blood Products Co., Ltd. (China) 18. Green Cross Corporation (South Korea) 19. Hualan Biological Engineering Inc. (China) 20. Reliance Life Sciences (India) 21. Zhejiang Medicine Co., Ltd. (China) 22. Takeda Pharmaceutical Company Ltd (Japan) 23. GC Pharma (South Korea) Middle East & Africa 24. Saudi Pharmaceutical Industries (Saudi Arabia) 25. Julphar Gulf Pharmaceutical Industries (UAE) 26. Biomarin FZ LLC (UAE) South America 27. Instituto Grifols S.A. (Argentina) 28. Hemobras (Brazil) 29. Laboratorio Pablo Cassara S.R.L. (Argentina) 30. Biosidus (Argentina)Fibrin Glue Market FAQs
1] What segments are covered in the Fibrin Glue Market report? Ans. The segments covered in the Fibrin Glue Market report are by type, by application and by End user. 2] Which region is expected to hold the highest share in the Fibrin Glue Market? Ans. The North America region is expected to hold the highest share in the Fibrin Glue Market. 3] What is the market size of the Fibrin Glue Market by 2032? Ans. The Fibrin Glue market size is expected to reach USD 1165.52 Mn by 2032. 4] What is the forecast period for the Fibrin Glue Market? Ans. The forecast period for the Fibrin Glue Market is 2025-2032. 5] What was the market size of the Fibrin Glue Market in 2024? Ans. The market size of the Fibrin Glue Market in 2024 was valued at USD 639.1 Mn.
1. Fibrin Glue Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Fibrin Glue Market: Competitive Landscape 2.1. Ecosystem Analysis 2.2. MMR Competition Matrix 2.3. Competitive Landscape 2.4. Key Players Benchmarking 2.4.1. Company Name 2.4.2. Business Segment 2.4.3. End-user Segment 2.4.4. Revenue (2024) 2.4.5. Company Locations 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 2.7. KANO Model Analysis 3. Fibrin Glue Market: Dynamics 3.1. Region wise Trends of Fibrin Glue Market 3.1.1. North America Fibrin Glue Market Trends 3.1.2. Europe Fibrin Glue Market Trends 3.1.3. Asia Pacific Fibrin Glue Market Trends 3.1.4. Middle East and Africa Fibrin Glue Market Trends 3.1.5. South America Fibrin Glue Market 3.2. Fibrin Glue Market Dynamics 3.2.1. Fibrin Glue Market Drivers 3.2.1.1. Rise in Complex Surgeries 3.2.1.2. Minimally Invasive Demand 3.2.1.3. Superiority over Sutures 3.2.2. Fibrin Glue Market Restraints 3.2.3. Fibrin Glue Market Opportunities 3.2.3.1. Emerging Markets Penetration 3.2.3.2. Technological Advancements 3.2.3.3. Strategic Collaborations 3.2.4. Fibrin Glue Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.4.1. Regulatory Approvals 3.4.2. Healthcare Spending 3.4.3. Blood Safety Norms 3.5. Fibrin Glue Usage Rate (%), by region 3.6. Technological Advancements in Fibrin Glue 3.7. Price Trend Analysis by Region 3.8. Technological Roadmap 3.9. Regulatory Landscape by Region 3.9.1. North America 3.9.2. Europe 3.9.3. Asia Pacific 3.9.4. Middle East and Africa 3.9.5. South America 3.10. Analysis of Government Schemes and Initiatives for Fibrin Glue Industry 3.11. Key Opinion Leader Analysis 4. Fibrin Glue Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 4.1. Fibrin Glue Market Size and Forecast, By Type (2024-2032) 4.1.1. Liquid 4.1.2. Patches 4.2. Fibrin Glue Market Size and Forecast, By Application (2024-2032) 4.2.1. Orthopaedic Surgery 4.2.2. Cardiovascular Surgery 4.2.3. General Surgery 4.2.4. Transplant Surgery 4.2.5. Others 4.3. Fibrin Glue Market Size and Forecast, By End User (2024-2032) 4.3.1. Hospitals 4.3.2. Speciality Clinics 4.3.3. Others 4.4. Fibrin Glue Market Size and Forecast, By Region (2024-2032) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Fibrin Glue Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 5.1. North America Fibrin Glue Market Size and Forecast, By Type (2024-2032) 5.1.1. Liquid 5.1.2. Patches 5.2. North America Fibrin Glue Market Size and Forecast, By Application (2024-2032) 5.2.1. Orthopaedic Surgery 5.2.2. Cardiovascular Surgery 5.2.3. General Surgery 5.2.4. Transplant Surgery 5.2.5. Others 5.3. Fibrin Glue Market Size and Forecast, By End User (2024-2032) 5.3.1. Hospitals 5.3.2. Speciality Clinics 5.3.3. Others 5.4. North America Fibrin Glue Market Size and Forecast, by Country (2024-2032) 5.4.1. United States 5.4.1.1. United States Fibrin Glue Market Size and Forecast, By Type (2024-2032) 5.4.1.1.1. Liquid 5.4.1.1.2. Patches 5.4.1.2. United States Fibrin Glue Market Size and Forecast, By Application (2024-2032) 5.4.1.2.1. Orthopaedic Surgery 5.4.1.2.2. Cardiovascular Surgery 5.4.1.2.3. General Surgery 5.4.1.2.4. Transplant Surgery 5.4.1.2.5. Others 5.4.1.3. United States Fibrin Glue Market Size and Forecast, By End User (2024-2032) 5.4.1.3.1. Hospitals 5.4.1.3.2. Speciality Clinics 5.4.1.3.3. Others 5.4.2. Canada 5.4.2.1. Canada Fibrin Glue Market Size and Forecast, By Type (2024-2032) 5.4.2.1.1. Liquid 5.4.2.1.2. Patches 5.4.2.2. Canada Fibrin Glue Market Size and Forecast, By Application (2024-2032) 5.4.2.2.1. Orthopaedic Surgery 5.4.2.2.2. Cardiovascular Surgery 5.4.2.2.3. General Surgery 5.4.2.2.4. Transplant Surgery 5.4.2.2.5. Others 5.4.2.3. Canada Fibrin Glue Market Size and Forecast, By End User (2024-2032) 5.4.2.3.1. Hospitals 5.4.2.3.2. Speciality Clinics 5.4.2.3.3. Others 5.4.3. Mexico 5.4.3.1. Mexico Fibrin Glue Market Size and Forecast, By Type (2024-2032) 5.4.3.1.1. Liquid 5.4.3.1.2. Patches 5.4.3.2. Mexico Fibrin Glue Market Size and Forecast, By Application (2024-2032) 5.4.3.2.1. Orthopaedic Surgery 5.4.3.2.2. Cardiovascular Surgery 5.4.3.2.3. General Surgery 5.4.3.2.4. Transplant Surgery 5.4.3.2.5. Others 5.4.3.3. Mexico Fibrin Glue Market Size and Forecast, By End User (2024-2032) 5.4.3.3.1. Hospitals 5.4.3.3.2. Speciality Clinics 5.4.3.3.3. Others 6. Europe Fibrin Glue Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 6.1. Europe Fibrin Glue Market Size and Forecast, By Type (2024-2032) 6.2. Europe Fibrin Glue Market Size and Forecast, By Application (2024-2032) 6.3. Europe Fibrin Glue Market Size and Forecast, By End User (2024-2032) 6.4. Europe Fibrin Glue Market Size and Forecast, by Country (2024-2032) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Fibrin Glue Market Size and Forecast, By Type (2024-2032) 6.4.1.2. United Kingdom Fibrin Glue Market Size and Forecast, By Application (2024-2032) 6.4.1.3. United Kingdom Fibrin Glue Market Size and Forecast, By End User (2024-2032) 6.4.2. France 6.4.2.1. France Fibrin Glue Market Size and Forecast, By Type (2024-2032) 6.4.2.2. France Fibrin Glue Market Size and Forecast, By Application (2024-2032) 6.4.2.3. France Fibrin Glue Market Size and Forecast, By End User (2024-2032) 6.4.3. Germany 6.4.3.1. Germany Fibrin Glue Market Size and Forecast, By Type (2024-2032) 6.4.3.2. Germany Fibrin Glue Market Size and Forecast, By Application (2024-2032) 6.4.3.3. Fibrin Glue Market Size and Forecast, By End User (2024-2032) 6.4.3.4. Germany Fibrin Glue Market Size and Forecast, By End User (2024-2032) 6.4.4. Italy 6.4.4.1. Italy Fibrin Glue Market Size and Forecast, By Type (2024-2032) 6.4.4.2. Italy Fibrin Glue Market Size and Forecast, By Application (2024-2032) 6.4.4.3. Italy Fibrin Glue Market Size and Forecast, By End User (2024-2032) 6.4.5. Spain 6.4.5.1. Spain Fibrin Glue Market Size and Forecast, By Type (2024-2032) 6.4.5.2. Spain Fibrin Glue Market Size and Forecast, By Application (2024-2032) 6.4.5.3. Spain Fibrin Glue Market Size and Forecast, By End User (2024-2032) 6.4.6. Sweden 6.4.6.1. Sweden Fibrin Glue Market Size and Forecast, By Type (2024-2032) 6.4.6.2. Sweden Fibrin Glue Market Size and Forecast, By Application (2024-2032) 6.4.6.3. Sweden Fibrin Glue Market Size and Forecast, By End User (2024-2032) 6.4.7. Russia 6.4.7.1. Russia Fibrin Glue Market Size and Forecast, By Type (2024-2032) 6.4.7.2. Russia Fibrin Glue Market Size and Forecast, By Application (2024-2032) 6.4.7.3. Russia Fibrin Glue Market Size and Forecast, By End User (2024-2032) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Fibrin Glue Market Size and Forecast, By Type (2024-2032) 6.4.8.2. Rest of Europe Fibrin Glue Market Size and Forecast, By Application (2024-2032) 6.4.8.3. Rest of Europe Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7. Asia Pacific Fibrin Glue Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 7.1. Asia Pacific Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.2. Asia Pacific Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.3. Asia Pacific Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4. Asia Pacific Fibrin Glue Market Size and Forecast, by Country (2024-2032) 7.4.1. China 7.4.1.1. China Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.1.2. China Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.1.3. China Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.2. S Korea 7.4.2.1. S Korea Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.2.2. S Korea Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.2.3. S Korea Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.3. Japan 7.4.3.1. Japan Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.3.2. Japan Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.3.3. Japan Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.4. India 7.4.4.1. India Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.4.2. India Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.4.3. India Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.5. Australia 7.4.5.1. Australia Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.5.2. Australia Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.5.3. Australia Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.6. Indonesia 7.4.6.1. Indonesia Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.6.2. Indonesia Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.6.3. Indonesia Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.7. Malaysia 7.4.7.1. Malaysia Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.7.2. Malaysia Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.7.3. Malaysia Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.8. Philippians 7.4.8.1. Philippians Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.8.2. Philippians Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.8.3. Philippians Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.9. Thailand 7.4.9.1. Thailand Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.9.2. Thailand Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.9.3. Thailand Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.10. Vietnam 7.4.10.1. Vietnam Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.10.2. Vietnam Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.10.3. Vietnam Fibrin Glue Market Size and Forecast, By End User (2024-2032) 7.4.11. Rest of Asia Pacific 7.4.11.1. Rest of Asia Pacific Fibrin Glue Market Size and Forecast, By Type (2024-2032) 7.4.11.2. Rest of Asia Pacific Fibrin Glue Market Size and Forecast, By Application (2024-2032) 7.4.11.3. Rest of Asia Pacific Fibrin Glue Market Size and Forecast, By End User (2024-2032) 8. Middle East and Africa Fibrin Glue Market Size and Forecast (by Value in USD Million) (2024-2032) 8.1. Middle East and Africa Fibrin Glue Market Size and Forecast, By Type (2024-2032) 8.2. Middle East and Africa Fibrin Glue Market Size and Forecast, By Application (2024-2032) 8.3. Middle East and Africa Fibrin Glue Market Size and Forecast, By End User (2024-2032) 8.4. Middle East and Africa Fibrin Glue Market Size and Forecast, by Country (2024-2032) 8.4.1. South Africa 8.4.1.1. South Africa Fibrin Glue Market Size and Forecast, By Type (2024-2032) 8.4.1.2. South Africa Fibrin Glue Market Size and Forecast, By Application (2024-2032) 8.4.1.3. South Africa Fibrin Glue Market Size and Forecast, By End User (2024-2032) 8.4.2. GCC 8.4.2.1. GCC Fibrin Glue Market Size and Forecast, By Type (2024-2032) 8.4.2.2. GCC Fibrin Glue Market Size and Forecast, By Application (2024-2032) 8.4.2.3. GCC Fibrin Glue Market Size and Forecast, By End User (2024-2032) 8.4.3. Egypt 8.4.3.1. Egypt Fibrin Glue Market Size and Forecast, By Type (2024-2032) 8.4.3.2. Egypt Fibrin Glue Market Size and Forecast, By Application (2024-2032) 8.4.3.3. Egypt Fibrin Glue Market Size and Forecast, By End User (2024-2032) 8.4.4. Nigeria 8.4.4.1. Nigeria Fibrin Glue Market Size and Forecast, By Type (2024-2032) 8.4.4.2. Nigeria Fibrin Glue Market Size and Forecast, By Application (2024-2032) 8.4.4.3. Nigeria Fibrin Glue Market Size and Forecast, By End User (2024-2032) 8.4.5. Rest of ME&A 8.4.5.1. Rest of ME&A Fibrin Glue Market Size and Forecast, By Type (2024-2032) 8.4.5.2. Rest of ME&A Fibrin Glue Market Size and Forecast, By Application (2024-2032) 9. South America Fibrin Glue Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 9.1. South America Fibrin Glue Market Size and Forecast, By Type (2024-2032) 9.2. South America Fibrin Glue Market Size and Forecast, By Application (2024-2032) 9.3. South America Fibrin Glue Market Size and Forecast, By Country (2024-2032) 9.3.1. Brazil 9.3.1.1. Brazil Fibrin Glue Market Size and Forecast, By Type (2024-2032) 9.3.1.2. Brazil Fibrin Glue Market Size and Forecast, By Application (2024-2032) 9.3.1.3. Brazil Fibrin Glue Market Size and Forecast, By End User (2024-2032) 9.3.2. Argentina 9.3.2.1. Argentina Fibrin Glue Market Size and Forecast, By Type (2024-2032) 9.3.2.2. Argentina Fibrin Glue Market Size and Forecast, By Application (2024-2032) 9.3.2.3. Argentina Fibrin Glue Market Size and Forecast, By End User (2024-2032) 9.3.3. Colombia 9.3.3.1. Colombia Fibrin Glue Market Size and Forecast, By Type (2024-2032) 9.3.3.2. Colombia Fibrin Glue Market Size and Forecast, By Application (2024-2032) 9.3.3.3. Colombia Fibrin Glue Market Size and Forecast, By End User (2024-2032) 9.3.4. Chile 9.3.4.1. Chile Fibrin Glue Market Size and Forecast, By Type (2024-2032) 9.3.4.2. Chile Fibrin Glue Market Size and Forecast, By Application (2024-2032) 9.3.4.3. Chile Fibrin Glue Market Size and Forecast, By End User (2024-2032) 9.3.5. Rest of South America 9.3.5.1. Rest of South America Fibrin Glue Market Size and Forecast, By Type (2024-2032) 9.3.5.2. Rest of South America Fibrin Glue Market Size and Forecast, By Application (2024-2032) 9.3.5.3. Rest of South America Fibrin Glue Market Size and Forecast, By End User (2024-2032) 10. Company Profile: Key Players (Detailed Profile for all Major Industry Players) 10.1. Johnson & Johnson (U.S) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Development 10.2. Baxter International Inc. (U.S) 10.3. Pfizer Inc. (U.S) 10.4. Grifols S.A. (U.S) 10.5. Haemonetics Corporation (U.S) 10.6. Integra LifeSciences (U.S) 10.7. CryoLife, Inc. (U.S) 10.8. Becton, Dickinson and Company (U.S) 10.9. Takeda Pharmaceutical (Switzerland) 10.10. B. Braun Melsungen AG (Germany) 10.11. Octapharma AG (Switzerland) 10.12. Biotest AG (Germany) 10.13. Kedrion Biopharma (Italy) 10.14. CSL Behring (Germany) 10.15. Ethicon (Belgium) 10.16. Vivostat A/S (Denmark) 10.17. Shanghai RAAS Blood Products Co., Ltd. (China) 10.18. Green Cross Corporation (South Korea) 10.19. Hualan Biological Engineering Inc. (China) 10.20. Reliance Life Sciences (India) 10.21. Zhejiang Medicine Co., Ltd. (China) 10.22. Takeda Pharmaceutical Company Ltd (Japan) 10.23. GC Pharma (South Korea) 10.24. Saudi Pharmaceutical Industries (Saudi Arabia) 10.25. Julphar Gulf Pharmaceutical Industries (UAE) 10.26. Biomarin FZ LLC (UAE) 10.27. Instituto Grifols S.A. (Argentina) 10.28. Hemobras (Brazil) 10.29. Laboratorio Pablo Cassara S.R.L. (Argentina) 10.30. Biosidus (Argentina) 11. Key Findings 12. Analyst Recommendations 13. Fibrin Glue Market: Research Methodology
